Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study.
暂无分享,去创建一个
M. Ramanathan | R. Benedict | M. Dwyer | R. Zivadinov | B. Weinstock-Guttman | D. Jakimovski | N. Bergsland